The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
In the latest session, Elanco Animal Health Inc (NYSE: ELAN) closed at $13.68 down -3.12% from its previous closing price of $14.12. In other words, the price has decreased by -$3.12 from its previous closing price. On the day, 5.41 million shares were traded. ELAN stock price reached its highest trading level at $14.205 during the session, while it also had its lowest trading level at $13.63.
Ratios:
For a deeper understanding of Elanco Animal Health Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 13.95 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 19.58. For the most recent quarter (mrq), Quick Ratio is recorded 1.46 and its Current Ratio is at 2.71. In the meantime, Its Debt-to-Equity ratio is 0.69 whereas as Long-Term Debt/Eq ratio is at 0.68.
On December 09, 2024, UBS started tracking the stock assigning a Buy rating and target price of $18.UBS initiated its Buy rating on December 09, 2024, with a $18 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 07 ’25 when Kurzius Lawrence Erik bought 10,000 shares for $10.90 per share. The transaction valued at 109,000 led to the insider holds 101,459 shares of the business.
Kurzius Lawrence Erik bought 10,000 shares of ELAN for $102,000 on Mar 11 ’25. The Director now owns 111,459 shares after completing the transaction at $10.20 per share. On Mar 05 ’25, another insider, HOOVER R DAVID, who serves as the Director of the company, bought 25,000 shares for $10.90 each. As a result, the insider paid 272,558 and bolstered with 210,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ELAN now has a Market Capitalization of 6794117632 and an Enterprise Value of 10702124032. As of this moment, Elanco’s Price-to-Earnings (P/E) ratio for their current fiscal year is 18.26, and their Forward P/E ratio for the next fiscal year is 14.36. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.95. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.53 while its Price-to-Book (P/B) ratio in mrq is 1.07. Its current Enterprise Value per Revenue stands at 2.417 whereas that against EBITDA is 12.401.
Stock Price History:
The Beta on a monthly basis for ELAN is 1.66, which has changed by 0.10948908 over the last 52 weeks, in comparison to a change of 0.18569505 over the same period for the S&P500. Over the past 52 weeks, ELAN has reached a high of $15.78, while it has fallen to a 52-week low of $8.02. The 50-Day Moving Average of the stock is -2.71%, while the 200-Day Moving Average is calculated to be 11.81%.
Shares Statistics:
For the past three months, ELAN has traded an average of 5.69M shares per day and 4622260 over the past ten days. A total of 496.46M shares are outstanding, with a floating share count of 491.95M. Insiders hold about 0.95% of the company’s shares, while institutions hold 100.32% stake in the company. Shares short for ELAN as of 1752537600 were 23568194 with a Short Ratio of 4.14, compared to 1749772800 on 24284022. Therefore, it implies a Short% of Shares Outstanding of 23568194 and a Short% of Float of 6.5600000000000005.
